We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WCC:NYSEWESCO International, Inc. Analysis

Data as of 2026-05-10 - not real-time

$355.31

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

WESCO delivered a strong Q1 2026, posting revenue of $6.08 billion (+13.8% YoY) and adjusted EPS of $3.37, beating consensus by roughly 18%. The price is trading at $355.31, comfortably above the 20‑day SMA (327.09), 50‑day SMA (294.61) and 200‑day SMA (258.15), while the MACD histogram remains positive (2.57) and the RSI sits at 66, indicating bullish momentum with a slight overbought tilt. Support sits near $297.48 and resistance near $368.90, with the stock already testing the upper band of its 52‑week range. Volatility is elevated (≈52% 30‑day) and beta is high (≈1.8), suggesting price swings may be pronounced.
Valuation appears attractive: the trailing P/E of 25.3 is below the industry average of 29.9 and the forward P/E of 19 signals upside potential, while the dividend yield of 0.56% is backed by a modest 13% payout ratio, implying sustainability. However, the balance sheet is leveraged (debt‑to‑equity ≈128) despite solid cash generation, so investors should monitor leverage. Overall, the combination of earnings beat, bullish technicals, and relative valuation advantage supports a positive outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Technical bullishness (price above all SMAs, positive MACD)
  • Q1 earnings beat and strong revenue growth
  • Support level provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to industry P/E
  • Sustainable dividend with low payout ratio
  • Continued revenue expansion across all three segments

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage (debt‑to‑equity >100) may limit flexibility
  • Elevated volatility and beta could amplify market swings
  • Long‑term growth prospects tied to industrial distribution demand

Key Metrics & Analysis

Financial Health

Revenue Growth13.80%
Profit Margin2.79%
P/E Ratio25.3
ROE13.40%
ROA5.13%
Debt/Equity127.71
P/B Ratio3.4
Op. Cash Flow$318.4M
Free Cash Flow$178.9M
Industry P/E29.9

Technical Analysis

TrendBullish
RSI66.5
Support$297.48
Resistance$368.90
MA 20$327.09
MA 50$294.61
MA 200$258.15
MACDBullish
VolumeIncreasing
Fear & Greed Index90.73

Valuation

Target Price$369.09
Upside/Downside3.88%
GradeUndervalued
TypeGrowth
Dividend Yield0.56%

Risk Assessment

Beta1.81
Volatility52.46%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.